Also known as: tension-type headache · TTH · muscle tension headache

Cannabis and Tension Headache

No clinical trials exist for cannabis specifically for tension-type headache, though some indirect mechanisms are plausible.

Automated fact-check pass
17 cited sources
Published
Last reviewed
How this page was made

This article is for information only and is not medical advice. Talk to a doctor before using cannabis for a health condition, and do not stop or change prescribed treatment on your own.

↯ The honest take

Tension-type headache is the most common headache disorder, yet cannabis hasn't been studied for it in controlled trials. People report relief anecdotally, probably through indirect routes—stress reduction, sleep, muscle relaxation. But there's no proof it treats TTH itself. Standard OTC painkillers, behavioral therapy, and preventive medications have far stronger evidence and cost less. Cannabis might help *some* people, but not as a primary headache drug.

Not Medical Advice

This article is not medical advice. It summarizes published evidence about cannabis and tension-type headache (TTH) for general education. Headache can be a symptom of serious conditions. If your headaches are new, severe, changing in pattern, or accompanied by neurological symptoms, see a clinician. Decisions about treatment—including whether to use cannabis—belong between you and a qualified healthcare provider who knows your full medical history.

Plain-Language Summary

Tension-type headache is the dull, band-like, bilateral head pain most people call a 'normal headache.' It is the most common primary headache disorder worldwide Strong evidence[1][2].

Despite its prevalence, there are no randomized controlled trials of cannabis or cannabinoids specifically for tension-type headache No data.

What we know:

What Probably Works for Tension-Type Headache

Nothing cannabis-related has earned a 'probably works' rating for tension-type headache No data.

No randomized controlled trial has tested THC, CBD, or whole-plant cannabis with tension-type headache as the primary outcome. Systematic reviews of cannabinoids for headache disorders consistently report this gap Strong evidence[3][5][6]. Until such trials are published, claims that a specific product, ratio, route, or strain treats TTH lack clinical support.

This is different from migraine and chronic headache, where preliminary signal exists (see Cannabis and Cluster Headache for related evidence).

What Might Work: Weak or Indirect Evidence

Several mechanisms make it biologically plausible that cannabis could help some people with tension headaches, without proving it does:

Stress and anxiety reduction. Psychological stress is a recognized trigger for TTH Strong evidence[2]. CBD has shown anxiolytic effects in some clinical contexts Weak / limited[7], and THC at low to moderate doses produces anxiolytic effects in some individuals and anxiogenic effects in others Weak / limited. If stress is your primary headache trigger, indirect benefit is theoretically possible.

Sleep. Poor sleep is associated with more frequent TTH episodes Strong evidence[2]. Cannabis has short-term effects on sleep latency Weak / limited[8], though long-term effects on overall sleep architecture remain mixed and uncertain Weak / limited.

Muscle tension. Pericranial muscle tenderness is a feature of TTH pathophysiology Strong evidence[1]. Cannabinoids interact with pain and muscle-tone pathways. However, evidence for cannabinoid-induced muscle relaxation in humans exists mainly in multiple sclerosis spasticity Strong evidence[9], not in TTH-related muscle tension No data.

General pain modulation. Cannabinoids show modest effects in chronic pain overall Weak / limited[9], but tension-type headache was not specifically studied in these reviews.

None of this proves cannabis treats tension headache. It means the proposed mechanisms are not implausible.

What Doesn't Work or Lacks Evidence

Common claims online that do not hold up to scrutiny:

'Indica strains relax tension headaches.' The indica/sativa distinction does not reliably predict chemical composition or subjective effects Disputed[10]. This claim is popular marketing folklore.

'High-CBD products cure tension headaches.' No controlled trial supports this for TTH No data. CBD has shown efficacy in epilepsy and specific anxiety contexts, not in headache disorders.

'Myrcene above 0.5% sedates and relieves headache.' The 0.5% myrcene threshold is widely repeated by dispensaries but has no published peer-reviewed source No data. It is popular dispensary folklore.

'Cannabis can replace OTC painkillers for treating tension headaches.' Direct clinical evidence for this claim does not exist No data. Standard analgesics have decades of clinical trial data; cannabis does not.

What We Don't Know

Nearly all clinically relevant questions remain unanswered:

This is genuinely unknown territory, not a 'researchers are about to confirm what users already know' situation.

Comparison with Standard Treatments

Treatments with stronger evidence for tension-type headache:

NSAIDs (ibuprofen, naproxen). First-line for episodic TTH. Effective in 50–70% of people, well-studied, rapid onset Strong evidence[3][4].

Acetaminophen/paracetamol. Second-line, less effective than NSAIDs but tolerated when NSAIDs are contraindicated Strong evidence[3][4].

Amitriptyline. First-line preventive for chronic TTH (≥15 headache days per month). Reduces frequency by 30–50% in clinical trials Strong evidence[4].

Behavioral approaches. Biofeedback, cognitive behavioral therapy, relaxation training, and stress management have meta-analytic support for chronic TTH Strong evidence[12].

Physical therapy and ergonomic changes. Posture correction, neck and shoulder stretching, and trigger avoidance have reasonable evidence for chronic TTH Weak / limited[2].

A practical framing: cannabis is not on the treatment ladder for tension-type headache. If it helps an individual, it likely does so through indirect routes (anxiety reduction, sleep improvement, general well-being) rather than as a targeted headache medication.

Risks and Caveats

Cannabis-induced headache. Acute intoxication, particularly with high-THC products, can trigger or worsen headache in some users Weak / limited.

Withdrawal headache. Headache is a recognized symptom of cannabis withdrawal in regular users, typically resolving within 48–72 hours of cessation Strong evidence[13].

Possible medication-overuse pattern. Daily use of any analgesic is associated with chronification of headache; whether cannabis fits this pattern is unestablished and requires further research Disputed.

Impairment. THC impairs driving and cognitive performance acutely Strong evidence[14]. Using cannabis before or during headache management may pose safety risks.

Interactions with medications. CBD inhibits cytochrome P450 enzymes and can raise levels of other medications, including some headache and cardiovascular drugs. See Cannabis and Polypharmacy Risks for details Strong evidence[15].

Pregnancy. Cannabis is not recommended during pregnancy due to potential effects on fetal development and neurodevelopment Strong evidence[16].

Mental health. Risk of anxiety, psychosis, or cannabis use disorder in vulnerable individuals Strong evidence[17].

Flag for clinician review. If you are treating frequent headaches with any agent—cannabis, ibuprofen, caffeine, triptans—and headache frequency is increasing, that warrants urgent evaluation to rule out medication-overuse headache or other secondary causes.

Sources

  1. Peer-reviewed Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211.
  2. Peer-reviewed Ashina S, Mitsikostas DD, Lee MJ, et al. Tension-type headache. Nature Reviews Disease Primers. 2021;7(1):24.
  3. Peer-reviewed Bendtsen L, Evers S, Linde M, et al. EFNS guideline on the treatment of tension-type headache—Report of an EFNS task force. European Journal of Neurology. 2010;17(11):1318–1325.
  4. Peer-reviewed Baron EP. Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science. Headache. 2018;58(7):1139–1186.
  5. Peer-reviewed Poudel S, Quinonez J, Choudhari J, et al. Medical Cannabis, Headaches, and Migraines: A Review of the Current Literature. Cureus. 2021;13(8):e17407.
  6. Peer-reviewed Cuttler C, Spradlin A, Cleveland MJ, Craft RM. Short- and Long-Term Effects of Cannabis on Headache and Migraine. The Journal of Pain. 2020;21(5–6):722–730.
  7. Peer-reviewed Blessing EM, Steenkamp MM, Manzanares J, Marmar CR. Cannabidiol as a Potential Treatment for Anxiety Disorders. Neurotherapeutics. 2015;12(4):825–836.
  8. Peer-reviewed Babson KA, Sottile J, Morabito D. Cannabis, Cannabinoids, and Sleep: a Review of the Literature. Current Psychiatry Reports. 2017;19(4):23.
  9. Peer-reviewed Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. JAMA. 2015;313(24):2456–2473.
  10. Peer-reviewed Piomelli D, Russo EB. The Cannabis sativa Versus Cannabis indica Debate: An Interview with Ethan Russo, MD. Cannabis and Cannabinoid Research. 2016;1(1):44–46.
  11. Peer-reviewed Diener HC, Holle D, Solbach K, Gaul C. Medication-overuse headache: risk factors, pathophysiology and management. Nature Reviews Neurology. 2016;12(10):575–583.
  12. Peer-reviewed Nestoriuc Y, Rief W, Martin A. Meta-analysis of biofeedback for tension-type headache: efficacy, specificity, and treatment moderators. Journal of Consulting and Clinical Psychology. 2008;76(3):379–396.
  13. Peer-reviewed Bonnet U, Preuss UW. The cannabis withdrawal syndrome: current insights. Substance Abuse and Rehabilitation. 2017;8:9–37.
  14. Peer-reviewed Hartman RL, Huestis MA. Cannabis effects on driving skills. Clinical Chemistry. 2013;59(3):478–492.
  15. Peer-reviewed Brown JD, Winterstein AG. Potential Adverse Drug Events and Drug-Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use. Journal of Clinical Medicine. 2019;8(7):989.
  16. Government American College of Obstetricians and Gynecologists. Committee Opinion No. 722: Marijuana Use During Pregnancy and Lactation. Obstetrics & Gynecology. 2017;130(4):e205–e209.
  17. Peer-reviewed Volkow ND, Baler RD, Compton WM, Weiss SRB. Adverse Health Effects of Marijuana Use. New England Journal of Medicine. 2014;370(23):2219–2227.

How this page was made

Generation history

Oct 30, 2026
Revision
Oct 29, 2026
Fact-check pass — raised 8 flags
Jun 7, 2026
Self-review — raised 3 flags
May 11, 2026
Fact-check pass — raised 3 flags
May 11, 2026
Initial draft

Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.